Quantbot Technologies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quantbot Technologies’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,582	Closed	-$1.79M	–	2222
2021 Q4	$1.79M	Buy	16,582 +10,864	+190%	+$1.19M	0.14%	203
2021 Q3	$626K	Buy	+5,718	New	+$594K	0.05%	522
2020 Q3	–	Sell	-2,633	Closed	-$146K	–	1783
2020 Q2	$146K	Buy	+2,633	New	+$113K	0.02%	504
2019 Q3	–	Sell	-29,180	Closed	-$702K	–	1717
2019 Q2	$702K	Buy	29,180 +18,448	+172%	+$468K	0.07%	320
2019 Q1	$283K	Sell	10,732 -2,011	-16%	-$47.7K	0.03%	592
2018 Q4	$248K	Buy	12,743 +8,802	+223%	+$173K	0.02%	604
2018 Q3	$77K	Buy	+3,941	New	+$74.9K	0.01%	944
2018 Q2	–	Sell	-47,292	Closed	-$671K	–	1656
2018 Q1	$671K	Sell	47,292 -29,953	-39%	-$442K	0.06%	411
2017 Q4	$1.13M	Buy	+77,245	New	+$1.08M	0.1%	280
2017 Q1	–	Sell	-39,888	Closed	-$645K	–	1530
2016 Q4	$645K	Buy	39,888 +33,682	+543%	+$611K	0.07%	291
2016 Q3	$112K	Buy	+6,206	New	+$121K	0.01%	705
2016 Q2	–	Sell	-3,542	Closed	-$58K	–	1499
2016 Q1	$58K	Sell	3,542 -28,776	-89%	-$503K	0.01%	846
2015 Q4	$700K	Buy	+32,318	New	+$629K	0.12%	198
2015 Q1	–	Sell	-454	Closed	-$5K	–	1486
2014 Q4	$5K	Buy	+454	New	+$5.68K	﹤0.01%	1042
2014 Q3	–	Sell	-6,203	Closed	-$98K	–	1525
2014 Q2	$98K	Sell	6,203 -4,371	-41%	-$62.4K	0.02%	739
2014 Q1	$159K	Buy	10,574 +1,147	+12%	+$13K	0.04%	491
2013 Q4	$71K	Buy	+9,427	New	+$50.8K	0.03%	517

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantbot Technologies's HZNP Position: Q1 2022 in Review

Quantbot Technologies sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2022, closing a stake of 16,582 shares — an estimated $1.79M sold.

Quantbot Technologies first reported a position in HZNP in Q4 2013 and held it in 17 quarters. The position peaked at $1.79M in Q4 2021. 620 funds tracked by Wall St. Rank hold HZNP as of Q1 2022.

Quantbot Technologies reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Quantbot Technologies sold 16,582 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2022, an estimated $1.79M.
Quantbot Technologies first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 17 quarters.
Quantbot Technologies's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.79M in Q4 2021.
620 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2022.

Based on Quantbot Technologies's 13F filing for Q1 2022, filed 16 May 2022.